GPT Healthcare Limited (BOM:544131)
India · Delayed Price · Currency is INR 127.75
-2.05 (-1.58%)
At close: Feb 13, 2026
GPT Healthcare Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Net Income | 499.22 | 477.69 | 390.08 | 416.63 | 210.93 |
Depreciation & Amortization | 184.58 | 176.68 | 147.84 | 135.31 | 123.97 |
Other Amortization | 5.72 | 3.14 | 1.28 | 0.59 | 0.75 |
Loss (Gain) From Sale of Assets | -3.35 | -1.83 | -4.51 | 0.01 | -6.48 |
Asset Writedown & Restructuring Costs | - | 2.85 | - | - | 9.36 |
Loss (Gain) From Sale of Investments | -4.01 | -2.9 | -1.79 | -1.93 | - |
Provision & Write-off of Bad Debts | 39.67 | 18.19 | 4.85 | 1.96 | 6.52 |
Other Operating Activities | -11.78 | 75.87 | 105.51 | 52.78 | 185.15 |
Change in Accounts Receivable | -1.44 | -46.05 | -77.36 | 36.42 | -6.11 |
Change in Inventory | -6.7 | 7.66 | -16.36 | -8.59 | -1.25 |
Change in Accounts Payable | -23.83 | 45.17 | 52.27 | 32.89 | -57.6 |
Change in Other Net Operating Assets | -4.11 | -68.48 | 61.75 | -6.15 | -25.96 |
Operating Cash Flow | 673.96 | 688 | 663.56 | 659.92 | 439.28 |
Operating Cash Flow Growth | -2.04% | 3.68% | 0.55% | 50.23% | 5.94% |
Capital Expenditures | -499.26 | -193.67 | -98.31 | -72.96 | -69.82 |
Sale of Property, Plant & Equipment | 4.89 | 1.51 | 14.61 | 1.79 | 8.6 |
Investment in Securities | -12.31 | -166.17 | -28.72 | -94.86 | - |
Other Investing Activities | 69.48 | -13.94 | 10.45 | 11.18 | 34.83 |
Investing Cash Flow | -325.92 | -252.06 | 51.53 | -53.39 | -173.85 |
Short-Term Debt Issued | 2.17 | 1.5 | - | 14.03 | - |
Long-Term Debt Issued | 93.97 | - | 2.45 | - | 184.25 |
Total Debt Issued | 96.14 | 1.5 | 2.45 | 14.03 | 184.25 |
Short-Term Debt Repaid | - | - | -13.52 | - | -53.31 |
Long-Term Debt Repaid | -141.46 | -570.65 | -322.53 | -303.09 | -79.56 |
Total Debt Repaid | -141.46 | -570.65 | -336.05 | -303.09 | -132.87 |
Net Debt Issued (Repaid) | -45.33 | -569.15 | -333.6 | -289.06 | 51.38 |
Issuance of Common Stock | - | 400 | - | - | - |
Preferred Dividends Paid | - | - | - | -47 | - |
Common Dividends Paid | -287.19 | -239.71 | -319.62 | -125.59 | - |
Dividends Paid | -287.19 | -239.71 | -319.62 | -172.59 | -134.38 |
Other Financing Activities | -15.87 | -76.14 | -78.56 | -109.96 | -138.13 |
Financing Cash Flow | -348.39 | -485.01 | -731.78 | -571.61 | -221.13 |
Net Cash Flow | -0.34 | -49.06 | -16.69 | 34.92 | 44.3 |
Free Cash Flow | 174.71 | 494.33 | 565.24 | 586.96 | 369.46 |
Free Cash Flow Growth | -64.66% | -12.55% | -3.70% | 58.87% | - |
Free Cash Flow Margin | 4.29% | 12.35% | 15.66% | 17.40% | 15.22% |
Free Cash Flow Per Share | 2.13 | 6.17 | 7.07 | 7.35 | 4.62 |
Cash Interest Paid | 15.87 | 51.35 | 78.56 | 109.96 | 138.13 |
Cash Income Tax Paid | 170.81 | 150.2 | 102.9 | 134.92 | -26.48 |
Levered Free Cash Flow | 224.99 | 517.21 | 559.51 | 528.32 | -54.34 |
Unlevered Free Cash Flow | 240.8 | 557.8 | 612.28 | 592.03 | 25.43 |
Change in Working Capital | -36.09 | -61.69 | 20.29 | 54.57 | -90.92 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.